NEVVI Medicare utilization intelligence

← back

Provider profile

REDDY, BIBAS D.O.

Medical Oncology · NPI 1457577017 · FORT WORTH, TX

1
Groups
36
Codes · 2024
48,853
Disclosed services

REDDY, BIBAS is a Medical Oncology in FORT WORTH, TX, a member of 1 medical group, who billed 36 distinct codes to Medicare Part B in 2024.

Groups: ONCOLOGY HEMATOLOGY CONSULTANTS, PA (FORT WORTH, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

48,853
disclosed services
36
codes billed to Medicare Part B
Prior year · CY2023 54,029 disclosed services

This provider's disclosed Medicare payments across all codes were premium in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg premiumpremium premiumpremium
J1453 Injection, fosaprepitant, 1 mg premiumpremium premiumpremium
J1756 Injection, iron sucrose, 1 mg premiumpremium premiumpremium
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units premiumpremium premiumpremium
J1100 Injection, dexamethasone sodium phosphate, 1 mg premiumpremium premiumpremium
J2469 Injection, palonosetron hcl, 25 mcg premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
96375 Injection of additional new drug or substance into vein premiumpremium premiumpremium
96413 Administration of chemotherapy into vein, 1 hour or less premiumpremium premiumpremium
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more premiumpremium premiumpremium
96372 Injection of drug or substance under skin or into muscle premiumpremium premiumpremium
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more premiumpremium premiumpremium
71260 Ct scan of chest with contrast premiumpremium premiumpremium
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less premiumpremium premiumpremium
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less premiumpremium premiumpremium
J1200 Injection, diphenhydramine hcl, up to 50 mg premiumpremium premiumpremium
74177 Ct scan of abdomen and pelvis with contrast premiumpremium premiumpremium
96415 Administration of chemotherapy into vein, each additional hour premiumpremium premiumpremium
96417 Administration of additional new drug or substance into vein, 1 hour or less premiumpremium premiumpremium
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's premiumpremium premiumpremium
78815 Nuclear medicine study from skull base to mid-thigh with ct scan premiumpremium premiumpremium
99426 Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month premiumpremium premiumpremium
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries premiumpremium premiumpremium
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes premiumpremium premiumpremium
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour premiumpremium premiumpremium
70491 Ct scan of soft tissue of neck with contrast premiumpremium premiumpremium
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more premiumpremium premiumpremium
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg premiumpremium premiumpremium
71250 Ct scan of chest without contrast premiumpremium premiumpremium
96360 Infusion into a vein for hydration, 31-60 minutes premiumpremium premiumpremium
J7030 Infusion, normal saline solution , 1000 cc premiumpremium premiumpremium
70553 Mri scan of brain before and after contrast premiumpremium premiumpremium
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more premiumpremium premiumpremium
99497 Advance care planning, first 30 minutes premiumpremium premiumpremium
74176 Ct scan of abdomen and pelvis without contrast premiumpremium premiumpremium
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.